CA
NVO

Cliff Asness’s Novo Nordisk NVO Stock Holding History

Cliff Asness’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
324,149
+143,020
+79% +$6.14M 0.01% 1299
2026
Q1 		$6.66M Buy
181,129
+39,719
+28% +$1.88M ﹤0.01% 1566
2025
Q4 		$7.19M Buy
141,410
+17,615
+14% +$901K ﹤0.01% 1368
2025
Q3 		$6.87M Sell
123,795
-1,655
-1% -$96.9K ﹤0.01% 1272
2025
Q2 		$8.66M Buy
125,450
+63,351
+102% +$4.31M 0.01% 1024
2025
Q1 		$4.31M Buy
62,099
+10,758
+21% +$889K ﹤0.01% 1202
2024
Q4 		$4.42M Buy
51,341
+353
+0.7% +$38.2K 0.01% 1158
2024
Q3 		$6.07M Buy
50,988
+33,824
+197% +$4.51M 0.01% 969
2024
Q2 		$2.45M Buy
17,164
+9,012
+111% +$1.19M ﹤0.01% 1368
2024
Q1 		$1.05M Buy
8,152
+2,990
+58% +$356K ﹤0.01% 1669
2023
Q4 		$534K Sell
5,162
-133
-3% -$13.2K ﹤0.01% 1850
2023
Q3 		$482K Buy
+5,295
New +$466K ﹤0.01% 1859

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cliff Asness's NVO Position: Q2 2026 in Review

Cliff Asness increased its Novo Nordisk (NVO) stake by 79% in Q2 2026, buying an estimated $6.14M and bringing the position to 324,149 shares worth $15.5M. The position accounts for 0.01% of the portfolio, ranked #1299.

Cliff Asness first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cliff Asness held 324,149 shares of Novo Nordisk worth $15.5M as of Q2 2026.
  • Cliff Asness bought 143,020 Novo Nordisk shares in Q2 2026, an estimated $6.14M.
  • Novo Nordisk made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #1299 holding.
  • Cliff Asness first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.